Design Therapeutics, Inc. (DSGN) Institutional Ownership & Insider Trading
137 institutions reported holding Design Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
DSGNDesign Therapeutics, Inc.Follow DSGN — free
—
Price chart with a free account
- Market cap
- 640.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters137 institutions held 69.2% of the shares. Across filers that reported both quarters, shares held changed +14.0%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 137 | 43 | +14.0% | 61 | 26 | 32 | 14 |
| Mar 26 | 125 | 38 | -0.5% | 50 | 18 | 28 | 12 |
| Dec 25 | 117 | 38 | +16.4% | 38 | 26 | 26 | 6 |
| Sep 25 | 95 | 36 | +4.4% | 17 | 13 | 38 | 10 |
| Jun 25 | 92 | 35 | +0.3% | 32 | 5 | 29 | 9 |
| Mar 25 | 98 | 34 | +3.1% | 20 | 12 | 33 | 8 |
| Dec 24 | 94 | 33 | +4.5% | 32 | 13 | 21 | 16 |
| Sep 24 | 100 | 32 | -15.7% | 27 | 12 | 30 | 8 |
Design Therapeutics, Inc. — questions
- Who owns Design Therapeutics, Inc. stock?
- 137 institutions reported Design Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: SR One Capital Management, LP (10.4%), Logos Global Management LP (4.8%), BAKER BROS. ADVISORS LP (4.3%).
Every figure on this page comes from Design Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.